352 related articles for article (PubMed ID: 21245043)
1. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
Andaloussi SE; Lehto T; Mäger I; Rosenthal-Aizman K; Oprea II; Simonson OE; Sork H; Ezzat K; Copolovici DM; Kurrikoff K; Viola JR; Zaghloul EM; Sillard R; Johansson HJ; Said Hassane F; Guterstam P; Suhorutšenko J; Moreno PM; Oskolkov N; Hälldin J; Tedebark U; Metspalu A; Lebleu B; Lehtiö J; Smith CI; Langel U
Nucleic Acids Res; 2011 May; 39(9):3972-87. PubMed ID: 21245043
[TBL] [Abstract][Full Text] [Related]
2. PepFect6 Mediated SiRNA Delivery into Organotypic Cultures.
Dash-Wagh S; Langel Ü; Ulfendahl M
Methods Mol Biol; 2016; 1364():27-35. PubMed ID: 26472439
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
[TBL] [Abstract][Full Text] [Related]
4. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
5. Influence of stearyl and trifluoromethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membrane.
Anko M; Majhenc J; Kogej K; Sillard R; Langel U; Anderluh G; Zorko M
Biochim Biophys Acta; 2012 Mar; 1818(3):915-24. PubMed ID: 22240008
[TBL] [Abstract][Full Text] [Related]
6. PTD/CPP peptide-mediated delivery of siRNAs.
Presente A; Dowdy SF
Curr Pharm Des; 2013; 19(16):2943-7. PubMed ID: 23140460
[TBL] [Abstract][Full Text] [Related]
7. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
[TBL] [Abstract][Full Text] [Related]
8. Transfection of infectious RNA and DNA/RNA layered vectors of semliki forest virus by the cell-penetrating peptide based reagent PepFect6.
Pärn K; Viru L; Lehto T; Oskolkov N; Langel Ü; Merits A
PLoS One; 2013; 8(7):e69659. PubMed ID: 23861978
[TBL] [Abstract][Full Text] [Related]
9. PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.
Lindberg S; Muñoz-Alarcón A; Helmfors H; Mosqueira D; Gyllborg D; Tudoran O; Langel U
Int J Pharm; 2013 Jan; 441(1-2):242-7. PubMed ID: 23200958
[TBL] [Abstract][Full Text] [Related]
10. A peptide-based vector for efficient gene transfer in vitro and in vivo.
Lehto T; Simonson OE; Mäger I; Ezzat K; Sork H; Copolovici DM; Viola JR; Zaghloul EM; Lundin P; Moreno PM; Mäe M; Oskolkov N; Suhorutšenko J; Smith CI; Andaloussi SE
Mol Ther; 2011 Aug; 19(8):1457-67. PubMed ID: 21343913
[TBL] [Abstract][Full Text] [Related]
11. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo.
Tai Z; Wang X; Tian J; Gao Y; Zhang L; Yao C; Wu X; Zhang W; Zhu Q; Gao S
Biomacromolecules; 2015 Apr; 16(4):1119-30. PubMed ID: 25686200
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6.
Dash-Wagh S; Jacob S; Lindberg S; Fridberger A; Langel U; Ulfendahl M
Mol Ther Nucleic Acids; 2012 Dec; 1(12):e61. PubMed ID: 23232329
[TBL] [Abstract][Full Text] [Related]
14. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
15. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
[TBL] [Abstract][Full Text] [Related]
16. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
18. Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA.
Ullah I; Chung K; Beloor J; Kim J; Cho M; Kim N; Lee KY; Kumar P; Lee SK
J Drug Target; 2017 Apr; 25(4):320-329. PubMed ID: 27820977
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
Wan Y; Moyle PM; Gn PZ; Toth I
Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
